Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk Acutely ill general medical patients are at moderate-to-high risk of venous thromboembolism (VTE); approximately 10–30% may develop deep vein thrombosis or pulmonary embolism, the latter being a leading contributor to deaths in hospital. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

Loading next page...
 
/lp/springer-journals/pharmacological-prevention-of-venous-thromboembolism-in-medical-wwmiqddmUy

References (78)

Publisher
Springer Journals
Copyright
Copyright © 2005 by Adis Data Information BV
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/00129784-200505060-00008
pmid
16259529
Publisher site
See Article on Publisher Site

Abstract

Acutely ill general medical patients are at moderate-to-high risk of venous thromboembolism (VTE); approximately 10–30% may develop deep vein thrombosis or pulmonary embolism, the latter being a leading contributor to deaths in hospital.

Journal

American Journal of Cardiovascular DrugsSpringer Journals

Published: Aug 20, 2012

There are no references for this article.